Predictive Oncology

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$3
$2
$110
$611
Gross Profit
-4
-15
65
320
EBITDA
-77,614
-1,808
-2,120
-1,550
EBIT
-77,646
-1,978
-2,287
-2,123
Net Income
-77,651
-2,070
-2,442
-2,169
Net Change In Cash
3
2
110
611
Free Cash Flow
-1,653
-3,323
-756
-3,042
Cash
181
506
3,087
734
Basic Shares
723
9,108
7,152
5,453

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$1,623
$1,627
$1,505
$1,420
Gross Profit
797
1,018
1,000
933
EBITDA
-10,243
-11,872
-13,954
-12,131
EBIT
-10,939
-12,117
-15,267
-13,471
Net Income
-12,201
-13,983
-25,737
-19,657
Net Change In Cash
1,623
1,627
1,505
1,420
Free Cash Flow
-11,965
-13,210
-12,846
-13,171
Cash
734
8,728
22,071
28,202
Basic Shares
5,453
4,014
3,685
2,743

Earnings Calls

QuarterEPS
2025-09-30
-$107.25
2025-06-30
-$0.22
2025-03-31
-$0.32
2024-12-31
-$0.24